274
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Facial Demodicosis-Induced Skin Hyperpigmentation in an Immunocompromised Man Treated Successfully with Ivermectin 1% Cream: A Case Report

ORCID Icon, ORCID Icon, &
Pages 1203-1207 | Received 08 Mar 2023, Accepted 25 Apr 2023, Published online: 08 May 2023

References

  • Baima B, Sticherling M. Demodicidosis revisited. Acta Derm Venereol. 2002;82(1):3–6. doi:10.1080/000155502753600795
  • Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Indian J Dermatol. 2014;59(1):60–66. doi:10.4103/0019-5154.123498
  • Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60(3):453–462. doi:10.1016/j.jaad.2008.10.058
  • Ayres S. Demodectic eruptions (demodicidosis) in the human. 30 years’ experience with 2 commonly unrecognized entities: pityriasis folliculorum (Demodex) and acne rosacea (Demodex type). Arch Dermatol. 1961;83:816–827. doi:10.1001/archderm.1961.01580110104016
  • Purcell SM, Hayes TJ, Dixon SL. Pustular folliculitis associated with Demodex folliculorum. J Am Acad Dermatol. 1986;15(5 Pt 2):1159–1162. doi:10.1016/s0190-9622(86)70287-9
  • Feuerman H, Atzmony L, Glick M, et al. Pigmented demodicidosis – an under-recognized cause of facial hyperpigmentation. Int J Dermatol. 2022;61(5):564–569. doi:10.1111/ijd.15992
  • Sereflican B, Tuman B, Boran C, Goksugu N, Parlak AH, Polat M. Facial pigmentation with demodex Mite; a mere coincidence or an association? Dermatol Online J. 2016;22(9):13030/qt4628m9xr.
  • Burns DA. Follicle mites and their role in disease. Clin Exp Dermatol. 1992;17(3):152–155. doi:10.1111/j.1365-2230.1992.tb00192.x
  • Blackmar FB. Pigmentation of roots of cilia caused by Acarus Demodex folliculorum. Am J Ophthalmol. 1929;12(5):373–375. doi:10.1016/s0002-9394(29)92280-7
  • Serpil S, Ulku K, Cemil C, Nasuhi Engin A, Sezai S, Meryem I. Positivity of Demodex spp. in biopsy specimens of nevi. Trop Biomed. 2009;26(1):51–56.
  • Seyhan ME, Karincaoğlu Y, Bayram N, Aycan O, Kuku I. Density of Demodex folliculorum in haematological malignancies. J Int Med Res. 2004;32(4):411–415. doi:10.1177/147323000403200410
  • Morrás PG, Santos SP, Imedio IL, Echeverría ML, Hermosa JM. Rosacea-like demodicidosis in an immunocompromised child. Pediatr Dermatol. 2003;20(1):28–30. doi:10.1046/j.1525-1470.2003.03006.x
  • Keles H, Pancar Yuksel E, Aydin F, Senturk N. Pre-treatment and post-treatment demodex densities in patients under immunosuppressive treatments. Medicina. 2020;56(3):107. doi:10.3390/medicina56030107
  • Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, Aycan O, Taskapan H. Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail. 2005;27(5):495–499. doi:10.1080/08860220500198037
  • Amitay-Laish I, Solomon-Cohen E, Feuerman H, et al. Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral center. Int J Dermatol. 2022;61(10):1245–1252. doi:10.1111/ijd.16162
  • Pormann AN, Vieira L, Majolo F, Johann L, Silva GL. Demodex folliculorum and demodex brevis (Acari: demodecidae) and their association with facial and non-facial pathologies. Int J Acarol. 2021;47(5):396–403. doi:10.1080/01647954.2021.1919757
  • Siddiqui K, Stein Gold L, Gill J. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis. Springerplus. 2016;5(1):1151. doi:10.1186/s40064-016-2819-8
  • Gupta M, Mahajan VK. Clinical profile of 300 men with facial hypermelanosis. J Dermatol Case Rep. 2017;11(2):20–24. doi:10.3315/jdcr.2017.1244
  • Taylor A, Pawaskar M, Taylor SL, Balkrishnan R, Feldman SR. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol. 2008;7(3):164–168. doi:10.1111/j.1473-2165.2008.00384.x